An Intersectional Analysis of Social Deprivation and Patient Characteristics on Nirmatrelvir-Ritonavir for Treatment of COVID-19 in U.S. Primary Care Practices, 2021 to 2023
Journal of Primary Care & Community Health · 2025
DOI: 10.1177/21501319251350935 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Primary Care & Community Health, 2025. Verfasst von Esther E Velásquez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Stanford University, Palo Alto, CA, USA. Hauptthemen laut MEDLINE: Ritonavir, Primary Health Care, COVID-19 Drug Treatment, Social Deprivation. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: FDA HHS, U.S. Food and Drug Administration.
Abstract (Originalsprache)
Objective
Calculate rates of nirmatrelvir-ritonavir prescription and assess area-level social deprivation as an effect modifier of patient characteristics on nirmatrelvir-ritonavir for the treatment of COVID-19.
Methods
Retrospective cohort study December 22, 2021 to June 30, 2023 using electronic health record (EHR) data of primary care patients from the American Family Cohort (AFC). Eligible patients had documented COVID-19 between December 15, 2021 and February 28, 2023; ≥1 healthcare encounter between January 1, 2020 and December 14, 2021; and ≥1 healthcare encounter between December 15, 2021 and June 30, 2023. Of the 3 678 474 AFC patients observed during the study period, 86 043 met inclusion criteria. Social deprivation was measured by census tract of patient residence using 2020 Social Deprivation Index (SDI) values; quintiles were calculated using national census tract distribution with lower values indicating less deprivation. The primary statistical analysis estimated the probability of nirmatrelvir-ritonavir prescription using logistic regression. The secondary analysis assessed area-level social deprivation as an effect modifier of patient characteristics on nirmatrelvir-ritonavir prescribing.
Results
Of the cohort, 26 797 (31.1%) patients were prescribed nirmatrelvir-ritonavir. Asian patients were more likely than White patients to receive a nirmatrelvir-ritonavir prescription in the lowest 2 quintiles of social deprivation (Q1: OR = 1.33 (95% CI = 1.10, 1.59); Q2: OR = 1.29 (95% CI = 1.02, 1.61)). Non-Hispanic/Latino patients in the lowest quintile had 1.32 times the odds of nirmatrelvir-ritonavir prescribing (95% CI = 1.12, 1.56) compared to Hispanic/Latino patients; however, in the third, fourth, and fifth quintiles, non-Hispanic/Latino patients had a reduced odds of a nirmatrelvir-ritonavir prescription compared to Hispanic/Latino patients (Q3: OR = 0.83 (95% CI = 0.73, 0.95); Q4: OR = 0.67 (95% CI = 0.60, 0.75); Q5: OR = 0.67 (95% CI = 0.56, 0.80)).
Conclusions
Our research suggests intersectionality between patient race/ethnicity with economic status – with meaningful implications for understanding access to new medications within primary care, as they relate to treatment for communicable diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stanford University, Palo Alto, CA, USA.
- University of Michigan, Ann Arbor, USA.
- University of North Carolina, Chapel Hill, USA.
- American Board of Family Medicine, Lexington, KY, USA.
- Center for Professionalism and Value in Health Care, Washington, DC, USA.
ORCID-Profile: Esther E Velásquez, Xiaoyu Wang
Förderung
- FDA HHS
- U.S. Food and Drug Administration
Zitieren
APA
Velásquez, E. E., Kamdar, N. S., Hendrix, N., Wang, X., Phillips, R. L., & Rehkopf, D. H. (2025). An Intersectional Analysis of Social Deprivation and Patient Characteristics on Nirmatrelvir-Ritonavir for Treatment of COVID-19 in U.S. Primary Care Practices, 2021 to 2023. Journal of Primary Care & Community Health. https://doi.org/10.1177/21501319251350935
Vancouver
Velásquez EE, Kamdar NS, Hendrix N, Wang X, Phillips RL, Rehkopf DH. An Intersectional Analysis of Social Deprivation and Patient Characteristics on Nirmatrelvir-Ritonavir for Treatment of COVID-19 in U.S. Primary Care Practices, 2021 to 2023. Journal of Primary Care & Community Health. 2025. doi:10.1177/21501319251350935
BibTeX
@article{Velsquez2025,
author = {Velásquez, Esther E and Kamdar, Neil S and Hendrix, Nathaniel and Wang, Xiaoyu and Phillips, Robert L and Rehkopf, David H},
title = {An Intersectional Analysis of Social Deprivation and Patient Characteristics on Nirmatrelvir-Ritonavir for Treatment of COVID-19 in U.S. Primary Care Practices, 2021 to 2023},
journal = {Journal of Primary Care & Community Health},
year = {2025},
doi = {10.1177/21501319251350935}
}
EUVIMED